Cargando…
Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects
The hereditary cancer syndromes, Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) and Succinate Dehydrogenase-related Hereditary Paraganglioma and Pheochromocytoma (SDH PGL/PCC), are linked to germline loss-of-function mutations in the fumarate hydratase (FH) and succinate dehydrogenase (SDH)...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072579/ https://www.ncbi.nlm.nih.gov/pubmed/30013182 http://dx.doi.org/10.1038/s41588-018-0170-4 |
_version_ | 1783344025987710976 |
---|---|
author | Sulkowski, Parker L. Sundaram, Ranjini K. Oeck, Sebastian Corso, Christopher D. Liu, Yanfeng Noorbakhsh, Seth Niger, Monica Boeke, Marta Ueno, Daiki Kalathil, Aravind Nambiar Bao, Xun Li, Jing Shuch, Brian Bindra, Ranjit S. Glazer, Peter M. |
author_facet | Sulkowski, Parker L. Sundaram, Ranjini K. Oeck, Sebastian Corso, Christopher D. Liu, Yanfeng Noorbakhsh, Seth Niger, Monica Boeke, Marta Ueno, Daiki Kalathil, Aravind Nambiar Bao, Xun Li, Jing Shuch, Brian Bindra, Ranjit S. Glazer, Peter M. |
author_sort | Sulkowski, Parker L. |
collection | PubMed |
description | The hereditary cancer syndromes, Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) and Succinate Dehydrogenase-related Hereditary Paraganglioma and Pheochromocytoma (SDH PGL/PCC), are linked to germline loss-of-function mutations in the fumarate hydratase (FH) and succinate dehydrogenase (SDH) genes encoding Krebs cycle enzymes, leading to elevated levels of fumarate and succinate, respectively(1–3). Here, we report that fumarate and succinate both suppress the homologous recombination (HR) DNA repair pathway required for the resolution of DNA double-strand breaks (DSBs) and for the maintenance of genomic integrity, rendering tumor cells vulnerable to synthetic lethal targeting with poly (ADP-ribose) polymerase (PARP) inhibitors. These results identify HLRCC and SDH PGL/PCC as familial DNA repair deficiency syndromes, providing a mechanistic basis to explain their cancer predisposition and pointing to a new therapeutic approach for advanced HLRCC and SDH PGL/PCC, both incurable when metastatic. |
format | Online Article Text |
id | pubmed-6072579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60725792019-01-16 Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects Sulkowski, Parker L. Sundaram, Ranjini K. Oeck, Sebastian Corso, Christopher D. Liu, Yanfeng Noorbakhsh, Seth Niger, Monica Boeke, Marta Ueno, Daiki Kalathil, Aravind Nambiar Bao, Xun Li, Jing Shuch, Brian Bindra, Ranjit S. Glazer, Peter M. Nat Genet Article The hereditary cancer syndromes, Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) and Succinate Dehydrogenase-related Hereditary Paraganglioma and Pheochromocytoma (SDH PGL/PCC), are linked to germline loss-of-function mutations in the fumarate hydratase (FH) and succinate dehydrogenase (SDH) genes encoding Krebs cycle enzymes, leading to elevated levels of fumarate and succinate, respectively(1–3). Here, we report that fumarate and succinate both suppress the homologous recombination (HR) DNA repair pathway required for the resolution of DNA double-strand breaks (DSBs) and for the maintenance of genomic integrity, rendering tumor cells vulnerable to synthetic lethal targeting with poly (ADP-ribose) polymerase (PARP) inhibitors. These results identify HLRCC and SDH PGL/PCC as familial DNA repair deficiency syndromes, providing a mechanistic basis to explain their cancer predisposition and pointing to a new therapeutic approach for advanced HLRCC and SDH PGL/PCC, both incurable when metastatic. 2018-07-16 2018-08 /pmc/articles/PMC6072579/ /pubmed/30013182 http://dx.doi.org/10.1038/s41588-018-0170-4 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Sulkowski, Parker L. Sundaram, Ranjini K. Oeck, Sebastian Corso, Christopher D. Liu, Yanfeng Noorbakhsh, Seth Niger, Monica Boeke, Marta Ueno, Daiki Kalathil, Aravind Nambiar Bao, Xun Li, Jing Shuch, Brian Bindra, Ranjit S. Glazer, Peter M. Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects |
title | Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects |
title_full | Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects |
title_fullStr | Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects |
title_full_unstemmed | Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects |
title_short | Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects |
title_sort | krebs cycle-deficient hereditary cancer syndromes are defined by homologous recombination dna repair defects |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072579/ https://www.ncbi.nlm.nih.gov/pubmed/30013182 http://dx.doi.org/10.1038/s41588-018-0170-4 |
work_keys_str_mv | AT sulkowskiparkerl krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT sundaramranjinik krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT oecksebastian krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT corsochristopherd krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT liuyanfeng krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT noorbakhshseth krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT nigermonica krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT boekemarta krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT uenodaiki krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT kalathilaravindnambiar krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT baoxun krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT lijing krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT shuchbrian krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT bindraranjits krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects AT glazerpeterm krebscycledeficienthereditarycancersyndromesaredefinedbyhomologousrecombinationdnarepairdefects |